Studies on Disease-Modifying Antirheumatic Drugs: Synthesis of Novel Quinoline and Quinazoline Derivatives and Their Anti-inflammatory Effect 1

A Baba, N Kawamura, H Makino, Y Ohta…

Index: Baba, Atsuo; Kawamura, Noriaki; Makino, Haruhiko; Ohta, Yoshikazu; Taketomi, Shigehisa; Sohda, Takashi Journal of Medicinal Chemistry, 1996 , vol. 39, # 26 p. 5176 - 5182

Full Text: HTML

Citation Number: 88

Abstract

In the course of our study aimed at developing new types of DMARDs (disease-modifying antirheumatic drugs), we found that quinoline derivative 1a had a potent anti-inflammatory effect in an adjuvant arthritis (AA) rat model, starting from the potent bone resorption ...

Related Articles:

Process development of a disease-modifying antirheumatic drug, TAK-603, based on optimization of Friedel–Crafts reaction and selective substitution of a triazole ring

[Mizuno, Masahiro; Inagaki, Atsushi; Yamashita, Makoto; Soma, Norie; Maeda, Yoshiharu; Nakatani, Hiroshi Tetrahedron, 2006 , vol. 62, # 17 p. 4065 - 4070]

Process development of a disease-modifying antirheumatic drug, TAK-603, based on optimization of Friedel–Crafts reaction and selective substitution of a triazole ring

[Mizuno, Masahiro; Inagaki, Atsushi; Yamashita, Makoto; Soma, Norie; Maeda, Yoshiharu; Nakatani, Hiroshi Tetrahedron, 2006 , vol. 62, # 17 p. 4065 - 4070]

Process development of a disease-modifying antirheumatic drug, TAK-603, based on optimization of Friedel–Crafts reaction and selective substitution of a triazole ring

[Mizuno, Masahiro; Inagaki, Atsushi; Yamashita, Makoto; Soma, Norie; Maeda, Yoshiharu; Nakatani, Hiroshi Tetrahedron, 2006 , vol. 62, # 17 p. 4065 - 4070]

Process development of a disease-modifying antirheumatic drug, TAK-603, based on optimization of Friedel–Crafts reaction and selective substitution of a triazole ring

[Mizuno, Masahiro; Inagaki, Atsushi; Yamashita, Makoto; Soma, Norie; Maeda, Yoshiharu; Nakatani, Hiroshi Tetrahedron, 2006 , vol. 62, # 17 p. 4065 - 4070]

Process development of a disease-modifying antirheumatic drug, TAK-603, based on optimization of Friedel–Crafts reaction and selective substitution of a triazole ring

[Mizuno, Masahiro; Inagaki, Atsushi; Yamashita, Makoto; Soma, Norie; Maeda, Yoshiharu; Nakatani, Hiroshi Tetrahedron, 2006 , vol. 62, # 17 p. 4065 - 4070]

More Articles...